Paul Isaac
Arbiter Partners Capital Management
Paul Isaac REVOLUTION HEALTHCARE -CW28 stake
total: 298
Arbiter Partners Capital Management REVHW trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q3
- Held for:
- 6 quarters
- Latest activity:
- 2023 Q1
According to 2026 Q2 report, Paul Isaac doesn't hold any REVOLUTION HEALTHCARE -CW28 (REVHW) shares. To date, the estimated cost basis is nearly $0.9 for "buy" trades. Arbiter Partners Capital Management first purchased REVHW in 2021 Q3, initially acquiring 17,780 shares. Since the initial investment in REVOLUTION HEALTHCARE -CW28 (REVHW), Arbiter Partners Capital Management has made 1 more transaction.
When did Paul Isaac sell REVOLUTION HEALTHCARE -CW28 (REVHW)?
Paul Isaac sold off the entire REVOLUTION HEALTHCARE -CW28 (REVHW) position in 2023 Q1.
When did Paul Isaac buy REVOLUTION HEALTHCARE -CW28 (REVHW)?
Paul Isaac first invested in REVOLUTION HEALTHCARE -CW28 (REVHW) in 2021 Q3 at the reported quarter-end price of $0.90 per share.
What's the cost basis of Arbiter Partners Capital Management's REVHW stake?
The estimated cost basis for REVOLUTION HEALTHCARE -CW28 (REVHW) stake is around $0.90 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $0.90
- Weighted AVG sell price:
- $0.00
Paul Isaac's historical trades in REVOLUTION HEALTHCARE -CW28
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q1
|
0.00%
|
0
|
$0.00
|
|
-100% (-17,780)
|
-0%
|
|
2021 Q3
|
0.01%
|
17,780
|
$0.90
|
$16,000
|
new
|
+0.01%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.